San Diego Chapter Meeting
DATE & TIME
Tuesday, February 21, 2012
6:00 PM - 8:00 PM
TITLE
Biosimilars - Wave of the Future or Child of the Privileged Few?
DESCRIPTION
Navigating successfully the maze of legal and regulatory requirements
governing pharmaceuticals, biologics, medical devices and other
FDA-regulated products requires experienced, well-honed insights and
understanding of both the bounds of the law and agency policy.
SPEAKER
Michael Swit
LOCATION
Rockbottom Brewery
8980 Villa La Jolla Drive
La Jolla, CA 92037
858-450-9277
ONLINE REGISTRATION
LES Member: $30
Non-Member: $40
LES Student Member: $25
Onsite
LES Member: $40
Non-Member: $50
LES Student Member: $30
Online Registration Deadline: Monday, February 20, 12 PM PST
CANCELLATION POLICY
No refunds after February 17
Substitutions permitted after February 17
SPEAKER BIO
Michael Swit
Michael Swit has been addressing critical FDA legal and regulatory issues since 1984. Before recently returning to private law practice, Mr. Swit served for seven years as a Vice President at The Weinberg Group, a preeminent scientific and regulatory consulting firm headquartered in Washington, D.C., where he developed and ensured execution of a broad array of regulatory and other services to clients, both directly and through outside counsel. His expertise includes FDA development strategies, compliance and enforcement initiatives, recalls and crisis management, submissions and related traditional FDA regulatory activities, labeling and advertising, and clinical research efforts for drug, biologic, device, IVD, and other life sciences companies, as well as those in the food and dietary supplement industries.